Acquired cold urticaria symptoms can be safely prevented by ebastine.

Acquired cold urticaria symptoms can be safely prevented by ebastine. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Acquired cold urticaria symptoms can be safely prevented by ebastine. Abstract Text:

M Magerl,J Schmolke,F Siebenhaar,T Zuberbier,M Metz,M Maurer,M Magerl,J Schmolke,F Siebenhaar,T Zuberbier,M Metz,M Maurer,

BACKGROUND: Acquired cold urticaria (ACU) is a skin condition, in which exposure to cold results in wheals and itching and sometimes general systemic complications. It has a profound impact on patient quality of life. Second-generation antihistamines are recommended as the first-line treatment, but to date only a few have been scientifically tested for this condition. AIM: To assess the safety and efficacy of ebastine in preventing ACU symptoms. METHODS: Twenty-two adult ACU patients participated in a double-blind crossover trial of 20 mg ebastine. The safety of ebastine was sensitively assessed with a psychometric battery testing cognitive performance and mood. After cold challenge, wheal and erythema were assessed by the investigator and the intensities of pruritus and burning were rated by the subject. RESULTS: Ebastine had no negative impact on any of the parameters of cognitive performance or mood. It dramatically reduced the number of patients who experienced wheals, pruritus, and burning after challenge. CONCLUSION: Ebastine is safe and effective in preventing the symptoms of ACU.

Acquired cold urticaria symptoms can be safely prevented by ebastine. Publishing Authors By Initials

M Magerl,J Schmolke,F Siebenhaar,T Zuberbier,M Metz,M Maurer,M Magerl,J Schmolke,F Siebenhaar,T Zuberbier,M Metz,M Maurer,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Acquired cold urticaria symptoms can be safely prevented by ebastine. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Allergy

VOLUME: 62

Page Numbers: 1465-8

Journal Abbreviation: Allergy

ISSN: 0105-4538

DAY: 26

MONTH: 09

YEAR: 2007

Acquired cold urticaria symptoms can be safely prevented by ebastine. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7804028

Acquired cold urticaria symptoms can be safely prevented by ebastine. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Acquired cold urticaria symptoms can be safely prevented by ebastine. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Acquired cold urticaria symptoms can be safely prevented by ebastine.

AFFILIATION: Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité- Universitätsmedizin Berlin, Berlin, Germany.

Country: Denmark

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Allergy

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Acquired cold urticaria symptoms can be safely prevented by ebastine Related Publications

• Acquired cold urticaria symptoms can be safely prevented by ebastine.
• Adaptive Designs in Clinical Drug Development: Opportunities, Challenges, and Scope Reflections Following PhRMA's November 2006 Workshop.
• Assessing combinations of cytotoxic agents using leukemia cell lines.
• Cell-permeable peptides induce dose- and length-dependent cytotoxic effects.
• Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy.
• Do All Patients with Community-acquired Pneumonia Need Antibiotics Within 4 Hours of Presentation?
• Early detection of schizophrenia: current evidence and future perspectives.
• Egg labeling methods for gastric emptying scintigraphy are not equivalent in producing a stable solid meal.
• Employing mutants to study thrombin residues responsible for factor XIII activation peptide recognition: a kinetic study.
• Exposure of bovine embryos to trypsin during washing does not decrease embryonic survival.
• Highly Efficient Enzymatic Synthesis of 2-Monoacylglycerides and Structured Lipids and their Production on a Technical Scale.
• Improving state pain policies: recent progress and continuing opportunities.
• Information fusion in biomedical image analysis: combination of data vs. combination of interpretations.
• Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry.
• Modelling socioeconomic and health determinants of health-care use: a semiparametric approach.
• Nuclear medicine training for radiology residents: needs assessment survey.
• Oxybutynin for hyperhidrosis.
• Perturbations in factor XIII resulting from activation and inhibition examined by solution based methods and detected by MALDI-TOF MS.
• Platelet binding and biodistribution of [99mTc]rBitistatin in animal species and humans.
• Powerful short-cuts for multiple testing procedures with special reference to gatekeeping strategies.
• Preservation of microelastic properties of dentin and tooth enamel in vitro--a scanning acoustic microscopy study.
• Requestioning depression in patients with cancer: Contribution of somatic and affective symptoms to Beck's Depression Inventory.
• Retropubic surgery.
• Shape-based averaging.
• Superovulation and embryo quality in beef cows using PMSG and a monoclonal anti-PMSG.
• The complex morphology of Maurer's clefts: from discovery to three-dimensional reconstructions.
• Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxym
• [In Process Citation]
• [Not Available.]
• [Not Available.]